ORIGINAL RESEARCH article

Front. Oncol.

Sec. Gynecological Oncology

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1599522

This article is part of the Research TopicRadiomics and AI-Driven Deep Learning for Cancer Diagnosis and TreatmentView all articles

Amide Proton Transfer-weighted Habitat Radiomics: A Superior Approach for Preoperative Prediction of Lymphovascular Space Invasion in Cervical Cancer

Provisionally accepted
Jie  LiJie LiYatong  LiYatong LiLianze  DuLianze DuQinghai  YuanQinghai YuanQinghe  HanQinghe Han*
  • Second Affiliated Hospital of Jilin University, Changchun, China

The final, formatted version of the article will be published soon.

Background: Non-invasive preoperative prediction of lymphovascular space invasion (LVSI) in cervical cancer (CC) is clinically important for guiding surgical planning and adjuvant therapy, while avoiding the risks associated with invasive procedures. However, current studies using amide proton transfer-weighted (APTw) MRI for LVSI prediction typically analyze only the mean values from a limited number of intratumoral regions of interest (ROIs), which fails to fully capture tumor heterogeneity. This study investigates the added value of whole-tumor APTw habitat radiomics in predicting LVSI and its advantages over conventional analysis methods.: This prospective study included consecutive adult patients with suspected CC who underwent APTw MRI between December 2022 and December 2024; a portion of the cohort has been reported previously. APTw values were extracted using two methods: (1) the conventional approach, calculating the mean signal from three ROIs on a representative slice; and (2) habitat radiomics, involving whole-tumor segmentation, k-means clustering to identify functional subregions, and radiomic feature extraction. Pathological assessment of LVSI from hysterectomy specimens served as the reference standard. Multivariable logistic regression identified variables associated with LVSI and developed diagnostic models. Model robustness was evaluated by 5-fold cross-validation, with AUC and DeLong's test used for performance assessment.Results: Among 124 patients (74 LVSI-, 50 LVSI+), the APTw_h3 model achieved a higher AUC (0.796 [95% CI: 0.709-0.882]) for predicting LVSI positivity than the clinical-radiological model (AUC = 0.733, 95% CI: 0.638-0.817). The combined model integrating clinical, radiological, and APTw_h3 features achieved the highest AUC (0.903, 95% CI: 0.841-0.952), which was significantly higher than those of both the clinical-radiological and APTw_h3 models (both P < 0.001). Moreover, the addition of APTw_h3 to the clinical-radiological model improved sensitivity (88% vs. 82%) and specificity (83.8% vs. 64.9%) for determining LVSI positivity.: Whole-tumor APTw habitat radiomics demonstrates superior performance over conventional mean-value APTw analysis for preoperative prediction of LVSI in CC. Notably, integrating habitat radiomic features with clinical and radiological parameters further improves predictive accuracy, demonstrating potential for enhanced individualized patient management.

Keywords: habitat radiomics, Amide Proton Transfer-weighted MRI, Lymphovascular space invasion, cervical cancer, Predictive Modeling

Received: 25 Mar 2025; Accepted: 23 Jun 2025.

Copyright: © 2025 Li, Li, Du, Yuan and Han. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Qinghe Han, Second Affiliated Hospital of Jilin University, Changchun, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.